K Ulbrich Selected Research

doxorubicin- N- (2- hydroxypropyl)methacrylamide copolymer conjugate

7/2005

Induction of systemic antitumour resistance with targeted polymers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Ulbrich Research Topics

Disease

27	Neoplasms (Cancer) 07/2017 - 02/2000
10	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013 - 02/2000
4	Carcinoma (Carcinomatosis) 07/2017 - 05/2001
4	Melanoma (Melanoma, Malignant) 07/2017 - 01/2001
4	B-Cell Lymphoma (Lymphoma, B Cell) 04/2008 - 01/2002
4	Infections 04/2007 - 03/2001
2	Breast Neoplasms (Breast Cancer) 07/2017 - 01/2002
2	Leukemia 08/2014 - 10/2003
2	Lymphoma (Lymphomas) 01/2013 - 04/2008
2	B-Cell Leukemia (Leukemia, B Cell) 10/2003 - 01/2002
2	Colorectal Neoplasms (Colorectal Cancer) 04/2002 - 09/2000
1	T-Cell Leukemia (Leukemia, T Cell) 04/2008
1	Prostatic Neoplasms (Prostate Cancer) 04/2007
1	Weight Loss (Weight Reduction) 08/2004
1	Neuroblastoma 02/2004
1	Adenocarcinoma 04/2002
1	Necrosis 04/2002
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Respiratory Insufficiency (Respiratory Failure) 01/2000

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 07/2017 - 02/2000
16	PolymersIBA 01/2015 - 03/2000
15	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014 - 02/2000
14	hydroxypropyl methacrylateIBA 08/2014 - 02/2000
8	N-(2-hydroxypropyl)methacrylamideIBA 08/2014 - 05/2001
5	Monoclonal AntibodiesIBA 10/2003 - 09/2000
4	Drug CarriersIBA 01/2015 - 09/2000
3	OligopeptidesIBA 01/2005 - 03/2000
3	ribonuclease SPLIBA 02/2004 - 01/2001
2	AntibodiesIBA 11/2006 - 02/2000
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 02/2004 - 05/2002
2	HydrazonesIBA 02/2003 - 07/2001
2	methacrylamideIBA 05/2002 - 05/2001
2	Biological ProductsIBA 05/2001 - 02/2000
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2017
1	NanogelsIBA 07/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2014
1	Cytostatic AgentsIBA 01/2011
1	Gemcitabine FDA Link 09/2008
1	IntegrinsIBA 04/2007
1	seryl- isoleucyl- lysyl- valyl- alanyl- valinamideIBA 04/2007
1	Peptides (Polypeptides)IBA 04/2007
1	Laminin (Merosin)IBA 04/2007
1	LigandsIBA 04/2007
1	Immune Sera (Antisera)IBA 11/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2006
1	doxorubicin- N- (2- hydroxypropyl)methacrylamide copolymer conjugateIBA 07/2005
1	Transaminases (Aminotransferases)IBA 08/2004
1	DuxonIBA 08/2004
1	EnzymesIBA 02/2004
1	Ribonucleases (Ribonuclease)IBA 02/2004
1	AntigensIBA 10/2003
1	Transferrin Receptors (Transferrin Receptor)IBA 02/2002
1	Transferrin (beta 2 Transferrin)IBA 02/2002
1	Antineoplastic Agents (Antineoplastics)IBA 02/2002
1	Immunoglobulin G (IgG)IBA 01/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2002
1	AmidesIBA 05/2001
1	BuffersIBA 01/2001
1	EstersIBA 01/2001
1	SolutionsIBA 01/2001
1	LectinsIBA 09/2000
1	Plant LectinsIBA 09/2000
1	Peanut AgglutininIBA 09/2000
1	XenobioticsIBA 09/2000
1	GalactosamineIBA 09/2000
1	Wheat Germ AgglutininsIBA 09/2000
1	Gly-Phe-Leu-GlyIBA 03/2000
1	Cathepsin BIBA 03/2000
1	Ethylene Glycol (Monoethylene Glycol)IBA 03/2000
1	Immunologic Factors (Immunomodulators)IBA 02/2000
1	Proteins (Proteins, Gene)FDA Link 02/2000
1	Cell Surface ReceptorsIBA 02/2000
1	Methohexital (Brevital)FDA Link 01/2000
1	Propofol (Diprivan)FDA LinkGeneric 01/2000

Therapy/Procedure

8	Therapeutics 08/2014 - 02/2000
1	Chemoradiotherapy 09/2008
1	Intravenous Administration 04/2007
1	Intravenous Injections 08/2004